Results 61 to 70 of about 27,951 (167)

Recurrent Henoch Schönlein purpura without renal involvement successfully treated with methotrexate

open access: yes, 2018
PubMedID: 30453828Introduction: Henoch Schönlein purpura is characterised by palpable purpura, abdominal pain, arthritis/arthralgia, often with a self-limiting course.
Balci S.   +6 more
core   +1 more source

Safety of Immune Checkpoint Inhibitors in Cancer Patients With Preexisting Autoimmune Vasculitis

open access: yesACR Open Rheumatology, Volume 8, Issue 3, March 2026.
Objective Immune checkpoint inhibitors (ICIs) are effective cancer therapies but often cause serious immune‐related adverse events (irAEs). Patients with preexisting autoimmune diseases, including vasculitis, are excluded from trials. We aimed to evaluate the frequency, severity, and outcomes of vasculitis flares and irAEs in this population.
Juan Sevillano   +4 more
wiley   +1 more source

Henoch-Schonlein purpura in children

open access: yes, 2013
Henoch-Schönlein purpura is the most common systemic vasculitis of childhood. In the majority of children, the outcome of Henoch-Schönlein purpura is excellent with spontaneous resolution of symptoms and signs.
Trnka, Peter
core   +1 more source

Koebner phenomenon in leukocytoclastic vasculitis: A case report and an updated review of the literature

open access: yesSAGE Open Medical Case Reports, 2019
Leukocytoclastic vasculitis is the most common form of cutaneous vasculitis. It is a neutrophilic small vessel vasculitis resulting from the deposition of circulating immune complexes.
Farah Kassam   +2 more
doaj   +1 more source

Henoch-Schönlein purpura in an older man presenting as rectal bleeding and IgA mesangioproliferative glomerulonephritis: a case report

open access: yesJournal of Medical Case Reports, 2011
Introduction Henoch-Schönlein purpura is the most common systemic vasculitis in children. Typical presentations are palpable purpura, abdominal pain, arthritis, and hematuria.
Howarth Charles B   +3 more
doaj   +1 more source

Fractional Microneedling Radiofrequency for Hidradenitis Suppurativa: A Real‐World Retrospective Study Demonstrating Clinical Efficacy and Safety Across Diverse Anatomical Sites

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 3, March 2026.
ABSTRACT Background Hidradenitis suppurativa (HS) remains a therapeutically challenging disease despite expanding research and evolving systemic treatments. Energy‐based modalities, such as fractional microneedling radiofrequency (FMR), are being increasingly explored as novel treatment options.
Ari Safir   +7 more
wiley   +1 more source

Henoch Schönlein Purpura Nephritis in Children: Review And Case Reports

open access: yes, 2017
Henoch–Schönlein purpura (HSP) is a small-vessel, immune complex-mediated, leukocytoclastic vasculitis. It is known to be the most common form of systemic vasculitis in childhood.
Lee, Eu Hyun
core  

Successful Treatment of Severe Purpura Fulminans With Anakinra

open access: yesPediatric Dermatology, Volume 43, Issue 2, Page 421-424, March/April 2026.
ABSTRACT Purpura fulminans (PF) is a rare, often fatal pediatric condition characterized by intravascular thrombosis and hemorrhagic infarction of the skin. A timely diagnosis and treatment are paramount to prevent the involvement of internal organs, causing disseminated intravascular coagulation and gangrene of the extremities.
Francesco Zulian   +4 more
wiley   +1 more source

Gastrointestinal Biopsy in Henoch-Schönlein Purpura: A Great Diagnostic Contribution [PDF]

open access: yes, 2017
Henoch-Schönlein purpura is an IgA-mediated immune vasculitis which is characterized by purpuric lesions and osteoarticular, intestinal and sometimes renal manifestations. The histopathological substrate of this entity is leucocytoclastic vasculitis (LCV)
Ben Jazia, Elhem   +5 more
core   +1 more source

Risk Factors of Disease Progression in IgA Nephropathy: A Systematic Review and Meta‐Analysis

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 2, February 2026.
ABSTRACT Objective IgA nephropathy (IgAN) is an important cause of chronic renal failure, and nearly all patients with IgAN are at risk of developing to end‐stage renal disease (ESRD) during their lifetime. This meta‐analysis aimed to identify and evaluate risk factors associated with the progression of IgAN patients.
Dan Xu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy